These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37935273)

  • 21. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.
    Siliprandi N; Di Lisa F; Menabò R
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():11-5. PubMed ID: 2031869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation.
    Fontaine M; Briand G; Vallée L; Ricart G; Degand P; Divry P; Vianey-Saban C; Vamecq J
    Clin Chim Acta; 1996 Aug; 252(2):109-22. PubMed ID: 8853559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
    Calvani M; Reda E; Arrigoni-Martelli E
    Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders.
    Bhattacharya K; Matar W; Tolun AA; Devanapalli B; Thompson S; Dalkeith T; Lichkus K; Tchan M
    Orphanet J Rare Dis; 2020 Feb; 15(1):53. PubMed ID: 32070364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
    Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
    Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
    Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
    Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between acid-soluble carnitine and coenzyme A pools in vivo.
    Brass EP; Hoppel CL
    Biochem J; 1980 Sep; 190(3):495-504. PubMed ID: 7470064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A liver-specific defect of Acyl-CoA degradation produces hyperammonemia, hypoglycemia and a distinct hepatic Acyl-CoA pattern.
    Gauthier N; Wu JW; Wang SP; Allard P; Mamer OA; Sweetman L; Moser AB; Kratz L; Alvarez F; Robitaille Y; Lépine F; Mitchell GA
    PLoS One; 2013; 8(7):e60581. PubMed ID: 23861731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. trans-3-Methylglutaconyl CoA isomerization-dependent protein acylation.
    Young R; Jones DE; Diacovich L; Witkowski A; Ryan RO
    Biochem Biophys Res Commun; 2021 Jan; 534():261-265. PubMed ID: 33280817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention by L-carnitine of DNA damage induced by 3-hydroxy-3-methylglutaric and 3-methylglutaric acids and experimental evidence of lipid and DNA damage in patients with 3-hydroxy-3-methylglutaric aciduria.
    Delgado CA; Balbueno Guerreiro GB; Diaz Jacques CE; de Moura Coelho D; Sitta A; Manfredini V; Wajner M; Vargas CR
    Arch Biochem Biophys; 2019 Jun; 668():16-22. PubMed ID: 31047871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.
    Yang C; Shi C; Zhou C; Wan Q; Zhou Y; Chen X; Jin X; Huang C; Xu P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):472-480. PubMed ID: 34704412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
    Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
    Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of carnitine in intracellular metabolism.
    Bremer J
    J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy.
    Vissing CR; Dunø M; Wibrand F; Christensen M; Vissing J
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5968-5976. PubMed ID: 31294795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria.
    Liepinsh E; Makrecka-Kuka M; Volska K; Kuka J; Makarova E; Antone U; Sevostjanovs E; Vilskersts R; Strods A; Tars K; Dambrova M
    Biochem J; 2016 May; 473(9):1191-202. PubMed ID: 26936967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
    J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.